Latest Breaking News On - Lymphoma tumor board - Page 1 : vimarsana.com

Dr Svoboda on the Efficacy of Armored huCART19-IL18 in R/R Lymphoma

Jakub Svoboda, MD, discusses outcomes with armored huCART19-IL18 in patients with previously treated relapsed/refractory lymphomas that have progressed.